Viewing Study NCT06018506


Ignite Creation Date: 2025-12-26 @ 5:19 PM
Ignite Modification Date: 2026-03-05 @ 10:31 AM
Study NCT ID: NCT06018506
Status: TERMINATED
Last Update Posted: 2025-11-21
First Post: 2023-08-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of BR108 in Hematological Malignancies
Sponsor: BioRay Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module